Fiduciary Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.8M | Buy |
17,519
+255
| +1% | +$114K | 0.1% | 126 |
|
|
2025
Q1 | $8.37M | Buy |
17,264
+4,104
| +31% | +$1.99M | 0.11% | 111 |
|
|
2024
Q4 | $5.3M | Buy |
13,160
+1,147
| +10% | +$462K | 0.07% | 157 |
|
|
2024
Q3 | $5.59M | Buy |
12,013
+2,183
| +22% | +$1.02M | 0.08% | 155 |
|
|
2024
Q2 | $4.61M | Buy |
9,830
+1,209
| +14% | +$567K | 0.07% | 160 |
|
|
2024
Q1 | $3.6M | Buy |
8,621
+1,369
| +19% | +$572K | 0.06% | 186 |
|
|
2023
Q4 | $2.95M | Buy |
7,252
+2,553
| +54% | +$1.04M | 0.05% | 204 |
|
|
2023
Q3 | $1.63M | Buy |
4,699
+149
| +3% | +$51.8K | 0.03% | 255 |
|
|
2023
Q2 | $1.6M | Buy |
4,550
+264
| +6% | +$92.9K | 0.03% | 262 |
|
|
2023
Q1 | $1.35M | Sell |
4,286
-160
| -4% | -$50.4K | 0.03% | 279 |
|
|
2022
Q4 | $1.28M | Buy |
4,446
+331
| +8% | +$95.6K | 0.03% | 299 |
|
|
2022
Q3 | $1.19M | Buy |
4,115
+689
| +20% | +$199K | 0.03% | 291 |
|
|
2022
Q2 | $966K | Buy |
3,426
+219
| +7% | +$61.8K | 0.02% | 334 |
|
|
2022
Q1 | $837K | Buy |
+3,207
| New | +$837K | 0.02% | 378 |
|
|
2021
Q4 | – | Sell |
-2,858
| Closed | -$519K | – | 669 |
|
|
2021
Q3 | $519K | Sell |
2,858
-65
| -2% | -$11.8K | 0.01% | 472 |
|
|
2021
Q2 | $590K | Sell |
2,923
-322
| -10% | -$65K | 0.01% | 433 |
|
|
2021
Q1 | $697K | Buy |
3,245
+1,172
| +57% | +$252K | 0.01% | 398 |
|
|
2020
Q4 | $490K | Buy |
+2,073
| New | +$490K | 0.01% | 432 |
|
|
2019
Q3 | – | Sell |
-2,333
| Closed | -$428K | – | 521 |
|
|
2019
Q2 | $428K | Buy |
2,333
+1,200
| +106% | +$220K | 0.01% | 372 |
|
|
2019
Q1 | $209K | Buy |
+1,133
| New | +$209K | 0.01% | 458 |
|
|
2018
Q4 | – | Sell |
-1,162
| Closed | -$224K | – | 469 |
|
|
2018
Q3 | $224K | Buy |
+1,162
| New | +$224K | 0.01% | 444 |
|